SR One News

BY CATEGORY: ALL / NOTABLE / CLINICAL IMPACT / NEW INVESTMENTS / FINANCING AND PARTNERSHIPS / PEOPLE

BY YEAR: 2023 / 2022 / 2021 / 2020

FDA accepts BLA for Reltecimod

Frances Benson 12/10/20 Frances Benson 12/10/20

FDA accepts BLA for Reltecimod

Read More

Repotrectinib treatment in TKI naive patients granted FDA breakthrough therapy designation

Frances Benson 12/8/20 Frances Benson 12/8/20

Repotrectinib treatment in TKI naive patients granted FDA breakthrough therapy designation

Read More

Cell therapy demonstrates durable responses in multiple myeloma

Frances Benson 12/7/20 Frances Benson 12/7/20

Cell therapy demonstrates durable responses in multiple myeloma

Read More

Update on gene editing for sickle cell disease and beta-thalassemia

Frances Benson 12/5/20 Frances Benson 12/5/20

Update on gene editing for sickle cell disease and beta-thalassemia

Read More

Morphic Therapeutic appoints Dr. Martin W. Edwards as Board Director

Frances Benson 12/4/20 Frances Benson 12/4/20

Morphic Therapeutic appoints Dr. Martin W. Edwards as Board Director

Read More

Palleon Pharmaceuticals appoints Deepa Pakianathan as Board Director

Frances Benson 12/4/20 Frances Benson 12/4/20

Palleon Pharmaceuticals appoints Deepa Pakianathan as Board Director

Read More

Pandion Therapeutics appoints Katina Dorton as Board Director

Frances Benson 12/3/20 Frances Benson 12/3/20

Pandion Therapeutics appoints Katina Dorton as Board Director

Read More

SR One Raises $500M; Completes Spinout from GSK

Frances Benson 11/19/20 Frances Benson 11/19/20

SR One Raises $500M; Completes Spinout from GSK

Read More

HotSpot Therapeutics appoints Eva Jack as COO

Frances Benson 11/17/20 Frances Benson 11/17/20

HotSpot Therapeutics appoints Eva Jack as COO

Read More

Decibel Therapeutics raises $82M Series D

Frances Benson 11/9/20 Frances Benson 11/9/20

Decibel Therapeutics raises $82M Series D

Read More

Mission Therapeutics appoints Dr. Suhail Nurbhai as CMO

Frances Benson 11/2/20 Frances Benson 11/2/20

Mission Therapeutics appoints Dr. Suhail Nurbhai as CMO

Read More

Turning Point Therapeutics raises $400M

Frances Benson 10/26/20 Frances Benson 10/26/20

Turning Point Therapeutics raises $400M

Read More

Early response data with gene edited cell therapy for B-cell malignancies

Frances Benson 10/21/20 Frances Benson 10/21/20

Early response data with gene edited cell therapy for B-cell malignancies

Read More

Design Therapeutics appoints Joao Siffert as CEO

Frances Benson 10/20/20 Frances Benson 10/20/20

Design Therapeutics appoints Joao Siffert as CEO

Read More

Nobel Prize in chemistry awarded to CRISPR Therapeutics founder Emmanuelle Charpentier

Frances Benson 10/20/20 Frances Benson 10/20/20

Nobel Prize in chemistry awarded to CRISPR Therapeutics founder Emmanuelle Charpentier

Read More

Dren Bio raises $60M Series A

Frances Benson 10/16/20 Frances Benson 10/16/20

Dren Bio raises $60M Series A

Read More

Frances Benson 10/15/20 Frances Benson 10/15/20

eFFECTOR Therapeutics appoints Premal Patel as CMO

Read More

Nimbus Therapeutics raises $60M

Frances Benson 10/14/20 Frances Benson 10/14/20

Nimbus Therapeutics raises $60M

Read More

Nkarta Therapeutics appoints Nadir Mahmood as CFO/CBO and Alicia J. Hager as Chief Legal Officer

Frances Benson 10/5/20 Frances Benson 10/5/20

Nkarta Therapeutics appoints Nadir Mahmood as CFO/CBO and Alicia J. Hager as Chief Legal Officer

Read More

Fore Biotherapeutics raises $57M Series C

Frances Benson 9/21/20 Frances Benson 9/21/20

Fore Biotherapeutics raises $57M Series C

Read More